Meister Supply Reasonable Price Good Quality Regorafenib CAS 755037-03-7
| Price | USD10.00 | USD15.00 | USD20.00 |
| Packge | 1kg | 1kg | 1kg |
- Min. Order:1kg
- Supply Ability:2000kg/Month
- Time:2022-07-05
Product Details
- Product NameRegorafenib
- CAS No.755037-03-7
- EINECS No.815-051-1
- MFC21H15ClF4N4O3
- MW482.82
- AppearanceWhite powder.Pale Pink to Light Pink
- Melting point 206.0 to 210.0 °C
- density 1.491±0.06 g/cm3(Predicted)
- Boiling point 513.4±50.0 °C(Predicted)
- storage temp. Refrigerator
Basic Info.
Model NO.
CAS 755037-03-7
Test Method
HPLC
Storage
Store Cool Dry Place
Market
Worldwide
Mf
C21h15clf4n4o3
MW
482.815
CAS
755037-03-7
Melting Point
206.0 to 210.0 °c
Transport Package
Aluminium Foil Bag
Specification
99%
Trademark
LINWO
Origin
China
Production Capacity
2000kg/Month
Product Description
| Product Name | Medical Raw Materials cas 1019206-88-2 raw Regorafenib hydrate powder |
| Appearance | White powder |
| Molecular formula | C21h17clf4n4o4 |
| Molecular Weight | 500.83 |
| Keywords | raw Regorafenib hydrate powder,raw Regorafenib hydrate,Raw Materials Regorafenib hydrate |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
Regorafenib is a small molecule inhibitor of multiple membrane-bound and intracellular kinases involved in normal cell function and pathological processes such as tumorigenesis, tumor angiogenesis, metastasis and tumor immunity.
Function
Regorafenib treatment of metastatic colorectal cancer in patients who have previously undergone fluoropyrimidine-, oxaliplatin-, and irinotecan-based therapies. The active metabolites of the drug inhibit multiple targets within a variety of kinase families including those in the RET, FGFR, PTK, and Abl pathways....
Regorafenib treatment of metastatic colorectal cancer in patients who have previously undergone fluoropyrimidine-, oxaliplatin-, and irinotecan-based therapies. The active metabolites of the drug inhibit multiple targets within a variety of kinase families including those in the RET, FGFR, PTK, and Abl pathways.
Company Profile Introduction
New material technology research and development、Technology popularization、
Technical consulting、Technology transfer、Medical technology r&d
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 755037-03-7 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- 755037-03-7 Regorafenib 98%
- Inquiry
- 2024-03-16
-
VIP1年
- NATCO Pharma Limited
- 755037-03-7 98%
- Inquiry
- 2024-01-25
- Since:2022-03-18
- Address: Room 601, Unit 1, Building 1, 188 Xinhuali, North Xinhua Road, Xiangdu District, Xingtai city, Hebei
INQUIRY